GSK transfers 22M treasury shares for stock awards
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
On November 20, 2026, GSK plc transferred 22,000,000 treasury ordinary shares to JPMorgan Chase Bank, N.A., the depositary for its ADR programme, to procure the issuance and transfer of 11,000,000 ADRs to the GlaxoSmithKline (US) Trust for awards under three company plans. The consideration received from the Trust’s trustee was $47.82 per ADR, representing $23.91 per ordinary share, funded by a contribution to the Trust from GlaxoSmithKline LLC.
Following the transfer, GSK will hold 248,881,064 ordinary shares in treasury and have 4,067,451,066 ordinary shares in issue, excluding treasury shares. Treasury shares represent 6.12% of voting rights; the total number of voting rights is 4,067,451,066.
Key Figures
Key Terms
American depositary receipts financial
Deferred Annual Bonus Plan technical
Disclosure Guidance and Transparency Rules regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.